Lexeo Therapeutics (LXEO) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -13

4 insiders sold $323K. No buys.

SellLouis Edward Tamayo$20KChief Financial Officerat $4.91 on Aug 18, filed Aug 19

SellLouis Edward TamayoChief Financial Officer$20Kat $4.91 on Aug 18, filed Aug 19

SellRichard Nolan Townsend$17KChief Executive Officerat $4.95 on Aug 18, filed Aug 19

SellRichard Nolan TownsendChief Executive Officer$17Kat $4.95 on Aug 18, filed Aug 19

SellJose Manuel Otero$6KChief Operating Officerat $4.96 on Aug 18, filed Aug 19

SellJose Manuel OteroChief Operating Officer$6Kat $4.96 on Aug 18, filed Aug 19

From SEC Form 4s, the newest filed Aug 19, 2026 · Insiders have 2 business days to file a trade

6 more filings on LXEO in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 9 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on LXEO with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Lexeo Therapeutics

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about LXEO's insider trades

As of Nov 2, 2026: Lexeo Therapeutics (LXEO) has 9 insider filings on record in the last 6 months, the newest filed Aug 19, 2026. Its Quality Score is -13 (Poor). Scores as of 7:14 PM ET, 15 minutes behind.

Are LXEO insiders buying or selling?

4 insiders sold $323K across 9 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Louis Edward Tamayo, Chief Financial Officer, sold $20K on Aug 18, 2026.

Who are LXEO's biggest insider sellers?

By the dollars of their sales in the last 6 months: Richard Nolan Townsend (Chief Executive Officer), 3 sales; Narinder Pal Bhalla (Chief Medical Officer), 1 sale; Louis Edward Tamayo (Chief Financial Officer), 2 sales. 4 insiders sold in all.

When did an LXEO insider last buy?

No LXEO insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Louis Edward Tamayo on Aug 18, 2026.

Lexeo Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.